Interested in stem cell developments.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
tomcat, no New Year holiday in the USA today but it has been declared a holiday for this MB.
You are right, fair, that's precisely why it has to be open until 4pm.
I hear you, rocky, and will be very interested in your evaluation of this. I do hope this particular deal is one that is not true to form, so to speak.
Unfortunately I have to agree it wouldn't be surprising but I certainly hope Terren Piezer is in this only for money. I will not be happy if he becomes the CEO. His Prometa appearance on 60 Minutes was so full of bs it qualified as pathetic.
That's an eyesential post Gastrodamus.
I think ACTC wants Roslin Institute as a partner but that's just my guess and the possibility you suggest is certainly worth looking into.
Roslin Bio-Med is a company that was formed by Roslin Institute and later sold to Geron. The ACTC deal is with Roslin Institute not with Roslin Bio-Med.
Yes, louisa, and those eyeballs have good vision.
elysse, so we might be watching Ted Williams coming up with the Red Sox? Well, just in case, we better hold on to those bubble gum cards!!
Precisely the point HotStock.
Funny thing, we didn't hear any complaints about the MMs on the run-up to 0.27
"Why beat yourself up about it?"
But dianne, I could own the float by now if I had bought at every low and sold at every high!!!
"need to close green!"
Lichar, what disaster is going to occur if it doesn't. The only thing I can think of is you may fall off your seat. I fear Gastrodamus has gotten you sitting too close to the edge of it. :)
If the vision of the subjects improves and there are also no safety issues, so much the better, no one will ignore that.
"Todays Trading has me at the Edge of my Seat."
Great report, Gastrodamus, thanks for keeping us informed. Maybe you are at the Tipping Point.
"The process to create GMP clinical grade HESC's has more to it than I first suspected."
Excellent research, rocky. And that is precisely why ACTC has been careful to make a very good choice to partner with on this.
Your post is certainly legitimate Derbyblood and also eminently understandable is selling 2.839M shares when you still have 31.74M left.
"...someone could make a small fortune by designing head gear that allowed you to walk down the street using your hand held communicator and not bump into others. It will come."
Yes, louisa, you are probably right but surely all those beeping heads will drive us totally insane!
louisa, good comments on the European Strategy. I personally think that Cha Bio, as we speak, is in good position to be helping ACTC also explore the possibilities for a China Strategy. I agree with your very strong buy and hold recommendation.
hopefulstem and Gastrodamus, on the other hand, should follow their sense of things and sell immediately.
Great interview.
I totally agree, rocky, that a lot of warrants are being exercised in the service of short term profits. That is absolutely the way most of those companies work. At the same time, ACTC is basically in a rather dramatic up channel indicating serious buying and I do think that some institutions are starting to take positions though probably, right now, through various fronts they will use until ACTC gets listed on a "respectable" exchange.
hopeful, when the big money wants to take a position they can move in and knock the PPS around quite a bit. They are happy to shake out as many shares as possible by putting you and all of us on this kind of emotional roller coaster. When this happens you just have to hold on.
gdsgds, you don't have avery good grasp of the story here. Then, again, I am not sure you want that.
Great work again rocky.
Good find louisa.
Not likely to gap down especially with low volume expected on pre-holiday but technicians might at this point like to see an initial drop after the open to complete a classic 3 wave down (down-up-down) retrace to then allow resumption of the rally.
hopeful, these sell-offs should be expected in runs like this.
Holding at 0.23 would augur well for the next upwave.
But in this case, of course, you have to be very careful about a new CEO. A major consideration is you don't want to hire a guy from some place like Pfizer who is going to be hedging the table to get a good deal for Pfizer.
I stand corrected dianne.
diannedawn, re your earlier post today:
"don't you think they would have had enough time, and the foresight, to have things ready to go when the hold was lifted???
what are they diddling around with?"
ACTC has made enormous strides and is hardly "diddling around" at this point so when you used language like that it made me think you are a basher, then I thought maybe not and I should apologize for my abrupt response to you, but it does look like you have hit this theme before (in exactly the same manner) and it seems especially designed to suggest to the board that ACTC, even as they make remarkable strides forward, may be seriously incompetent as in this post from a little while ago:
"I'm no fan of the FDA, but right now I'm wondering why it took ACTC so long to put together this response to the FDA?
Didn't they already have all this data?"
Once again, Nicely, it shows great judgment on the part of ACTC since they made Lanza the CSO, not the CFO. And that is working very nicely, thank you.
Re: "..Granted this is the best news to date for ACTC but we are still a year/years away from significant data."
Three months away from significant data would be closer to the truth and to equate CBAI with ACTC is close to ridiculous.
louisa, how can you say that? To believe that you would have to believe that a great American or other corporation could behave like "...a great vampire squid wrapped around the face of humanity, relentlessly jamming its blood funnel into anything that smells like money."
Wait a second, maybe there is a major company trying to buy up ACTC.
Hey, louisa, I was very close to being serious. :)
louisa, I would say that is an absolutely clear indication that Pfizer is going after ACTC and they want you on their side.
DeGette Says She Has Support For Stem Cell Bill
Nov 26, 2010 11:55 am US/Mountain(AP) ? Colorado congresswoman Diana DeGette thinks she has enough bipartisan support to pass a stem cell research bill.
What's less certain is whether Congress will take on the issue when members return to work after the Thanksgiving break. Passing the defense authorization bill and addressing the Bush tax cuts could be higher priorities.
U.S. Rep. Doug Lamborn of Colorado Springs — who opposes the bill — tells the Durango Herald he doesn't think there will be enough time to take up the issue.
President Barack Obama has allowed government-funded research on embryonic stem cells but a federal appeals court is considering whether that violates a 1996 law prohibiting the use of tax dollars in work that harms an embryo. DeGette's bill would allow the research to continue.
http://cbs4denver.com/wireapnewsco/DeGette.says.she.2.2024370.html
FDA Approves ACT’s Embryonic Stem Cell Trial For Blindness – Should We Get Excited?
http://singularityhub.com/2010/11/24/fda-approves-acts-embryonic-stem-cell-trial-for-blindness-should-we-get-excited/
It's even in Aljazeeera:
http://english.aljazeera.net/news/americas/2010/11/2010112283946837987.html
Back to green right now. And, I think, in the longer run ahead more green than red.